Primary Human Cells & Specialized Assays
Forecast New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- Points of contact
-
- CBER Acquisition Liaison cberacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is procuring primary human cells, tissue sourcing, and general assay kits, with solicitation release estimated for May 1, 2027 and award anticipated September 1, 2027. High-quality human cells are a non-negotiable requirement to produce physiologically relevant, actionable data for the agency's work.
The estimated award value ranges from $25,000 to $250,000. Interested vendors should direct inquiries to cberacquisitions@fda.hhs.gov.
Forecast text
Funding for primary human cells, tissue sourcing, and general assay kits. High-quality human cells are non-negotiable for producing physiologically relevant, actionable data.
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast